PDCD1 and neoplasm: Thus, our immediate reaction to this observation was the vision that concurrent blockade of PD-L1/PD-1 should take the brake off and thus enhance the Nano-DOX-induced anti-tumor activation of TAMs, ultimately resulting in synergistic therapeutic efficacy.